POSTERS & PUBLICATIONS
From the latest randomized trials and methodologies to solid research results, find all the information you need. Click on any media below to download.
POSTERS
ISSCR
06.30.2020
ISSCR 2020 Virtual
A Single IV Dose of Plinabulin Induces Sustained Mobilization of CD34+ Cells in Humans Through A Mechanism of Action Independent From G-CSF or CXCR4 and Without Causing Bone Pain or Thrombocytopenia
AACR
06.23.2020
American Association for Cancer Research (AACR) Virtual Annual Meeting (2020)
Plinabulin, a Microtubule Destabilizing Agent, Improves Tumor Control by Enhancing Dendritic Cell Maturation and CD8 T Cell Infiltration in Combination with Immunoradiotherapy
ASCO
05.30.2020
American Society of Clinical Oncology (ASCO) Virtual Scientific Program (2020)
Head-to-Head Comparison of the Non-G-CSF Small Molecule Single Agent (SA) Plinabulin with SA Pegfilgrastim for the Prevention of Docetaxel Chemotherapy (Chemo)-Induced Neutropenia (CIN) in the PROTECTIVE-1 Trial
NCCN
03.20.2020
National Comprehensive CancerNetwork (NCCN) Annual Conference (2020)
Plinabulin, a Potent Inducer of Haptoglobin Production for the Prevention of Tissue Iron Overload in Patients Receiving Blood Transfusions Chronically
ISSCR
06.30.2020
ISSCR 2020 Virtual
A Single IV Dose of Plinabulin Induces Sustained Mobilization of CD34+ Cells in Humans Through A Mechanism of Action Independent From G-CSF or CXCR4 and Without Causing Bone Pain or Thrombocytopenia
AACR
06.23.2020
American Association for Cancer Research (AACR) Virtual Annual Meeting (2020)
Plinabulin, a Microtubule Destabilizing Agent, Improves Tumor Control by Enhancing Dendritic Cell Maturation and CD8 T Cell Infiltration in Combination with Immunoradiotherapy
PUBLICATIONS
Cancer Chemotherapy and Pharmacology
12.06.2019
Cancer Chemotherapy and Pharmacology
Plinabulin ameliorates neutropenia induced by multiple chemotherapies through a mechanism distinct from G-CSF therapies
Chem
11.14.2019
Chem
Structure, Thermodynamics, and Kinetics of Plinabulin Binding to Two Tubulin Isotypes
Cell Reports
09.24.2019
Cell Reports
GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-Tumor Responses
Investigational New Drugs
02.16.2011
Investigational New Drugs
Phase 1 Study of the Novel Vascular Disrupting Agent Plinabulin (NPI-2358) and Docetaxel
Cancer Chemotherapy and Pharmacology
12.06.2019
Cancer Chemotherapy and Pharmacology
Plinabulin ameliorates neutropenia induced by multiple chemotherapies through a mechanism distinct from G-CSF therapies
Chem
11.14.2019
Chem
Structure, Thermodynamics, and Kinetics of Plinabulin Binding to Two Tubulin Isotypes